Try GOLD - Free
'FICCI Heal 2019 - Health Of Healthcare In India'
Bio Spectrum
|September 2019
“No public-private demarcation for the agenda of improving healthcare in India”
-
Dr VK Paul, Member (Health), NITI Aayog, Government of India said that the public and private sectors in the healthcare sector have come together and are fully committed to serve the people of India, speaking at ‘FICCI HEAL 2019 - Health of Healthcare in India’, organised by FICCI supported by NITI Aayog and National Health Authority.
“Most important highlight of Ayushman Bharat is that it has now finally established ‘One India, one nation, one health sector’. Private-public demarcations are over once and for all. We are working together on agreed terms and methodologies through dialogue and systems with an endeavour to find solutions to the challenges of our healthcare system” he said.
Dr Paul said that over the last year, country has added 25 per cent additional MBBS seats, which is unprecedented. “From about 60,000 MBBS seats last year, this year we have about 76,000 seats and actually a potential of about 80,000 seats,” he said.
This story is from the September 2019 edition of Bio Spectrum.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 9,500+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Bio Spectrum
Bio Spectrum
Are BioStartUps in a Funding/Innovation Rut?
At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.
10 mins
September 2025
Bio Spectrum
HealthQuad appoints Namit Chugh as Director
Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the appointment of Namit Chugh as Director at HealthQuad, India's leading healthcare-focused growth venture capital platform.
1 min
September 2025
Bio Spectrum
Why Is Endoscopy Crucial for Gl Cancer Diagnosis?
The increased demand for gastrointestinal (GI) diagnostics in India, driven by rising disease rates and awareness of early intervention, is not evenly distributed. While major urban hospitals have expanded their endoscopic capabilities, many semi-urban and rural areas face limited access. Addressing this disparity is crucial for extending the benefits of early disease detection across the country.
4 mins
September 2025
Bio Spectrum
New England Biolabs launches NEBNext low-bias small RNA library prep kit
US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.
1 min
September 2025
Bio Spectrum
Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels
Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.
1 min
September 2025
Bio Spectrum
Dr. Moopen's Legacy Scholarship & Fellowships to aid 25 students from across India
In a path breaking initiative to make medical education accessible to meritorious students and students from economically challenged backgrounds, Padma Shri Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare and a globally recognised philanthropist, has announced an annual scholarship programme Dr. Moopen's Legacy Scholarship & Fellowships Programme aimed at supporting meritorious students seeking admissions in Dr. Moopen's Medical College, Dr Moopen's Nursing College and Dr Moopen's College of Pharmacy in Wayanad, Kerala.
1 min
September 2025
Bio Spectrum
Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr
Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.
1 min
September 2025
Bio Spectrum
"Shortage of professionals with expertise in both AI and life sciences complicates adoption"
With its ability to both generate insights and act on them autonomously, agentic AI is poised to revolutionise the process of developing new therapies and bringing them to the market.
5 mins
September 2025
Bio Spectrum
Al/loT-Driven Real-time Cardiac Event Prediction & Treatment
It is anticipated that between 2025 and 2050, a significant 50.2 per cent increase in cardiovascular mortality rates will result in 35.6 million cardiovascular deaths by 2050, of which ischemic heart disease or coronary heart disease will remain the leading cause, accounting for 56.2 per cent of fatalities in 2050.
2 mins
September 2025
Bio Spectrum
SCHOTT announces launch of syringe and cartridge glass tubing in India
SCHOTT, a global pioneer in specialty glass, has announced the addition of syringe and cartridge glass tubing to its existing state-ofthe-art manufacturing capabilities in Jambusar, Gujarat.
1 min
September 2025
Translate
Change font size